MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

(2011) A. L. Rivera et al.   NEURO-ONCOLOGY

MGMT gene promoter methylation in pediatric glioblastomas

(2010) Arti Srivastava et al.   CHILDS NERVOUS SYSTEM

Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas

(2010) Francesca R. Buttarelli et al.   CHILDS NERVOUS SYSTEM

Long-term outcomes in children with glioblastoma

(2010) Kyung Sun Song et al.   Journal of Neurosurgery-Pediatrics

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients

(2010) C.-K. Park et al.   NEURO-ONCOLOGY

Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: A report from the children's oncology group

(2010) Ian F. Pollack et al.   PEDIATRIC BLOOD & CANCER

Pediatric glioblastomas: A histopathological and molecular genetic study

(2008) Vaishali Suri et al.   NEURO-ONCOLOGY